Blaine Davis

Chief Financial OfficeratCartesian Therapeutics· In proxies 2023–2025

Pay in FY2025-51% from the year before · Cartesian Therapeutics stock -59.7% the same year

Blaine Davis was paid $1.9M in FY2025 (Dec), down 51%. Cartesian Therapeutics stock fell 59.7% that year.

Pay$100 in the stock at the end of FY22 → $21

Pay is from the Summary Compensation Table of each Cartesian Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

RNAC
Cartesian TherapeuticsPublic company · 3 yr
- Chief Financial Officer2023 – Present · 3 yrStock in role -77%

Roles come from the proxy statements of each company.

Activity

Pay
Cartesian Therapeutics CFO pay fell 51% to $1.9M. The stock fell 60% in FY2025 (Dec).
DEF 14AApr 28, 2026
Pay
Cartesian Therapeutics CFO pay rose 59% to $4.0M. The stock fell 13% in FY2024 (Dec).
DEF 14AApr 28, 2025

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?